Release Forms:


  • active substance: loratadine;
  • 1 tablet contains loratadine (in terms of 100% substance) 10 mg;
  • excipients: lactose, monohydrate; povidone; potato starch; magnesium stearate.

Dosage form. Tablets.

Main physical and chemical properties: white tablets, flat-cylindrical shape with beveled edges, with a dash on one side.

10 tablets in a blister; 1 or 10 blisters in a box.

10 tablets in a blister; 1 or 10 blisters in a box.

Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.

Hypersensitivity to any of the components of the drug.

Administered orally. The tablets can be used with or without food.
Adults and children from 12 years old: 10 mg (1 tablet) once a day.
For children from 2 to 12 years old, dosage depends on body weight. Children weighing more than 30 kg: 10 mg (1 tablet) once a day. Children weighing less than 30 kg: use loratadine in the appropriate dosage form (syrup).
Patients with impaired liver function.
Patients with severe liver dysfunction should be prescribed the drug at a lower initial dose, since they may have a decrease in the clearance of loratadine. For adults and children weighing more than 30 kg, the recommended starting dose is 10 mg every other day.
Patients with impaired renal function.
No dose adjustment is necessary for patients with impaired renal function.
Elderly patients.
There is no need for dose adjustment for elderly patients.